Pacific Biosciences
37°28′43″N 122°09′03″W / 37.4787°N 122.1507°W
| Company type | Public |
|---|---|
| Industry | Biotechnology |
| Founded | 2004 |
| Headquarters | , United States |
Key people |
|
| Revenue | US$200.5 million (2023) |
| US$−306.7 million (2023) | |
| Total assets | US$1.75 billion (2023) |
Number of employees | 575 (Q4 2024) |
| Website | pacb |
| Footnotes / references PacBio Q4 2023 results | |
Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.